Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
Authors:
- Carmine ZoccaliCarmine Zoccali
- Francesca MallamaciFMFrancesca Mallamaci
- Renke MaasRMRenke Maas
- Francesco A. BenedettoFBFrancesco A. Benedetto
- Giovanni TripepiGTGiovanni Tripepi
- Lorenzo S. MalatinoLorenzo S. Malatino
- Alessandro CataliottiACAlessandro Cataliotti
- Ignazio BellanuovaIBIgnazio Bellanuova
- Rainer BögerRBRainer Böger
- on behalf of The Creed InvestigatorsOIon behalf of The Creed Investigators
- 1 July 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (1) , 339-345
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranesKidney International, 2001
- Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patientsKidney International, 2001
- Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal diseaseKidney International, 2000
- Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patientsJournal Of Hypertension, 1999
- Indices of activity of the nitric oxide system in hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- Outcome and risk factors for left ventricular disorders in chronic uraemiaNephrology Dialysis Transplantation, 1996
- Ageing induces left ventricular concentric remodelling in normotensive subjectsJournal Of Hypertension, 1995
- Regulation off constitutive nitric oxide synthase activity by the human heartThe American Journal of Cardiology, 1995
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992